Dimensional Fund Advisors
CTXR icon

Dimensional Fund Advisors’s Citius Pharmaceuticals CTXR Stock Holding History

Dimensional Fund Advisors’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-558
Closed -$14K – 3424
2019
Q2 		$14K Hold
558
– – ﹤0.01% 3459
2019
Q1 		$20K Hold
558
– – ﹤0.01% 3433
2018
Q4 		$14K Hold
558
– – ﹤0.01% 3441
2018
Q3 		$24K Hold
558
– – ﹤0.01% 3415
2018
Q2 		$32K Hold
558
– – ﹤0.01% 3350
2018
Q1 		$43K Buy
+558
New +$51.3K ﹤0.01% 3317

Other funds holding CTXR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAAM
Baker Avenue Asset Management San Francisco, California $4.43B AUM 26.6% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return

Dimensional Fund Advisors's CTXR Position: Q3 2019 in Review

Dimensional Fund Advisors sold out of Citius Pharmaceuticals (CTXR) in Q3 2019, closing a stake of 558 shares — an estimated $14K sold.

Dimensional Fund Advisors first reported a position in CTXR in Q1 2018 and held it in 6 quarters. The position peaked at $43K in Q1 2018. 11 funds tracked by Wall St. Rank hold CTXR as of Q3 2019.

  • Dimensional Fund Advisors reported no remaining Citius Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Dimensional Fund Advisors sold 558 Citius Pharmaceuticals shares in Q3 2019, an estimated $14K.
  • Dimensional Fund Advisors first reported a position in Citius Pharmaceuticals in Q1 2018 and held it in 6 quarters.
  • Dimensional Fund Advisors's Citius Pharmaceuticals position peaked at $43K in Q1 2018.
  • 11 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q3 2019.

Based on Dimensional Fund Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.